Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Vascular Allografts Market Growth From $1.97 Billion In 2026 To $2.58 Billion By 2030 At A CAGR Of 7%
The vascular allografts market has shown strong expansion in recent years. Its size is expected to increase from $1.84 billion in 2025 to $1.97 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. Historically, this growth can be linked to the restricted availability of donor grafts, the reliance on conventional surgical procedures, the escalating prevalence of cardiovascular diseases, the expansion of hospital infrastructure, and the initial adoption of cortical and cancellous grafts.
The vascular allografts market is projected to experience substantial expansion in the coming years. This market is predicted to reach a valuation of $2.58 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. Key factors contributing to this anticipated growth include advancements in graft preservation and processing technologies, an increase in minimally invasive vascular procedures, the growing number of transplant surgeries, a rise in the application of composite and polymer-based materials, and the broadening reach of research and academic institutions in regenerative medicine. Significant trends expected during this period involve a surge in the need for vascular allografts in cardiovascular surgeries, a greater reliance on cortical and cancellous allografts, the wider acceptance of fresh frozen and freeze-dried grafts, an expansion in peripheral vascular and transplant procedures, and a strong emphasis on innovations in biologic and composite materials.
Get A Free Sample Report With In-Depth Market Insights:
Vascular Allografts Market Growth Drivers: What’s Behind The Acceleration?
The projected expansion of the vascular allografts market is driven by the rising occurrence of cardiovascular diseases. These illnesses encompass a range of conditions impacting the heart and circulatory system, specifically including coronary heart disease, heart failure, stroke, and hypertension. The growing incidence of cardiovascular diseases largely stems from unhealthy dietary practices, where overconsumption of saturated fats, trans fats, added sugars, and sodium leads to issues like high blood pressure, obesity, and increased cholesterol. Vascular allografts improve treatment possibilities for cardiovascular diseases by supplying pre-prepared donor blood vessels, making them suitable for individuals with compromised or ailing vessels. These allografts lead to better surgical results through re-establishing adequate blood circulation, minimizing adverse events, and promoting lasting cardiovascular well-being. For example, GOV.UK, a government body in the UK, indicated in December 2024 that approximately 2.24 million adults in England, representing about 4.4% of individuals aged 18 and above, had a GP-diagnosed case of CKD in March 2024. This figure represents an increase from the 2.09 million cases recorded during the prior year. Consequently, the rising occurrence of cardiovascular diseases is fueling the expansion of the vascular allografts market.
Vascular Allografts Market Segment Landscape And Growth Outlook
The vascular allografts market covered in this report is segmented –
1) By Type: Cortical Allograft, Cancellous Allograft, Corticocancellous Allograft
2) By Material Type: Biologic Materials, Synthetic Materials, Composite Materials, Polymer-Based Materials
3) By Application: Cardiovascular Surgery, Peripheral Vascular Surgery, Transplant Surgery, Repair Of Congenital Defects
4) By Distribution Channel: Direct Sales, Online Sales, Distributors, Medical Supply Stores
5) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research And Academic Institutions
Subsegments:
1) By Cortical Allograft: Structural Cortical Allografts, Segmental Cortical Allografts, Shaped Cortical Allografts, Machined Cortical Allografts
2) By Cancellous Allograft: Granular Cancellous Allografts, Block Cancellous Allografts, Molded Cancellous Allografts, Injectable Cancellous Allografts
3) By Corticocancellous Allograft: Composite Corticocancellous Allografts, Block Corticocancellous Allografts, Shaped Corticocancellous Allografts, Structural Corticocancellous Allografts
Vascular Allografts Market Trends: What’s Defining The Industry’s Next Phase?
Leading companies operating within the vascular allografts market are concentrating on developing advanced products, such as bioengineered graft materials, to improve graft durability, biocompatibility, and integration with the host tissue. Bioengineered graft material refers to specially designed vascular grafts created using sophisticated biological and engineering techniques. For instance, in February 2025, Humacyte Inc., a US-based biotechnology company, introduced Symvess, a bioengineered vascular graft specifically developed for adults needing urgent revascularization due to extremity arterial injuries when autologous vein grafts are not a viable option. Symvess is engineered to remodel into the patient’s own tissue over time, decreasing the risk of rejection and enhancing long-term outcomes. This graft also reduces the need for immunosuppressive drugs, presenting a significant advantage in trauma and emergency surgical situations.
Vascular Allografts Market Company Landscape And Competitive Strategy
Major companies operating in the vascular allografts market are Medtronic plc, Boston Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Dentsply Sirona Inc., Integra LifeSciences Holdings Corporation, MicroPort Scientific Corporation, Bioventus Inc., KLS Martin Group, MTF Biologics, MTF Biologics, ZimVie Inc., B. Braun Melsungen AG, Artivion Inc., MiMedx Group Inc., RTI Surgical Inc, LeMaitre Vascular Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Osteogenics Biomedical Inc.
View The Full Vascular Allografts Market Report:
Vascular Allografts Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the vascular allografts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular allografts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
